Autopsy report · NCT01715012

Study of ST266 in Diabetic Subjects With Deep Burns Managed With Skin Grafts

“Enrollment futility”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 2 years 5 months before it stopped.
• 1 participant enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Noveome Biotherapeutics, formerly Stemnion

Sponsor type

Industry

Conditions

Third Degree Burns; Diabetes

Interventions

ST266; Saline

Participants

1

Sites

1

Countries

United States

Trials that died the same way

• Optimal Number of Hyperbaric Oxygen Treatments for Carbon Monoxide Poisoning
  “Futility of enrollment.” (95% match in meaning)
• CPT-3 in Normal Pressure Hydrocephalus
  “Inadequate enrollment” (75% match in meaning)
• (SGB) in Men Treated for Prostate Cancer Improve Hot Flashes
  “Enrollment issues” (72% match in meaning)
• The Safety of Transdermal Nicotine Immediately Following an Acute Coronary Syndrome
  “Difficulties with enrollment.” (72% match in meaning)
• AVAD: Asthma With Small Airways Dysfunction
  “difficulties of enrollment” (71% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.